CenterBook Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
CenterBook Partners's LLY Position: Q2 2026 in Review
CenterBook Partners reduced its Eli Lilly (LLY) stake by 21% in Q2 2026, selling an estimated $6.25M and leaving 23,135 shares worth $27.7M. The position accounts for 1.36% of the portfolio, ranked #11.
CenterBook Partners first reported a position in LLY in Q2 2022 and has held it in 14 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- CenterBook Partners held 23,135 shares of Eli Lilly worth $27.7M as of Q2 2026.
- CenterBook Partners sold 6,121 Eli Lilly shares in Q2 2026, an estimated $6.25M.
- Eli Lilly made up 1.36% of CenterBook Partners's portfolio in Q2 2026, its #11 holding.
- CenterBook Partners first reported a position in Eli Lilly in Q2 2022 and has held it in 14 quarters since.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.